Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLQ | O75417 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17974951 | 0.89 | POLQ (0.48) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL12204057 | 0.85 | SMN1; SMN2 (0.37) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL21941064 | 0.80 | HIF1A (0.43) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL7464556 | 0.80 | ALDH1A1 (0.55) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL3822083 | 0.80 | NQO1 (0.48) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL1421836 | 0.80 | SMN1; SMN2 (0.42) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL3825486 | 0.75 | MEN1 (0.42) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL13012202 | 0.75 | SMN1; SMN2 (0.50) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL19330128 | 0.75 | SMN1; SMN2 (0.42) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A | |
| SCHEMBL2545947 | 0.75 | SMN1; SMN2 (0.42) | SMN1; SMN2NPC1ALDH1A1MAPK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125023-A2 | SOLUBLE FORMS OF INCLUSION COMPLEXES OF HISTONE DEACETYLASE INHIBITORS AND CYCLODEXTRINS, THEIR PREPARATION PROCESSES AND USES IN THE PHARMACEUTICAL FIELD | Universita'Degli Studi di Roma "La Sapienza" (IT) | 2009-12-02 | — | — | EP | claimed |
| WO-2008090585-A2 | SOLUBLE FORMS OF INCLUSION COMPLEXES OF HISTONE DEACETYLASE INHIBITORS AND CYCLODEXTRINS, THEIR PREPARATION PROCESSES AND USES IN THE PHARMACEUTICAL FIELD | UNIVERSITÀ DEGLI STUDI DI ROMA LA SAPIENZA (IT) | 2008-07-31 | — | — | WO | claimed |
| US-20240018102-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY | Lhotse Bio, Inc (US) | 2024-01-18 | — | — | US | disclosed |
| EP-2125023-A2 | SOLUBLE FORMS OF INCLUSION COMPLEXES OF HISTONE DEACETYLASE INHIBITORS AND CYCLODEXTRINS, THEIR PREPARATION PROCESSES AND USES IN THE PHARMACEUTICAL FIELD | Universita'Degli Studi di Roma "La Sapienza" (IT) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008090585-A2 | SOLUBLE FORMS OF INCLUSION COMPLEXES OF HISTONE DEACETYLASE INHIBITORS AND CYCLODEXTRINS, THEIR PREPARATION PROCESSES AND USES IN THE PHARMACEUTICAL FIELD | UNIVERSITÀ DEGLI STUDI DI ROMA LA SAPIENZA (IT) | 2008-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018102-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY | LPAR1, LPAR2, LPAR5 | SMN1; SMN2 1526/4885NPC1 183/4885ALDH1A1 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.